echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > World Alzheimer's Day Primary progressive aphasia and its subtyping

    World Alzheimer's Day Primary progressive aphasia and its subtyping

    • Last Update: 2022-10-02
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    September 21, 2022 is the 29th World Alzheimer's Day, and the theme is "Know Thyself, Know Others, Prevent Early, Wise Ahead – Hand in Hand for the Future"
    .

    Let's learn about primary progressive aphasia and its subtyping today
    .


    Author: Han Ying
    Wenyuan: "Subjective Cognitive Decline" public account



    1.



    Primary progressive aphasia (PPA) is a class of cognitive syndromes
    of progressive development.



    In the past 10 years, according to the clinical manifestations of language impairment and atrophic brain areas, primary progressive aphasia has been mainly divided into three types: non-fluent primary progressive aphasia (nfvPPA), semantic primary progressive aphasia (semantic variant PPA, svPPA), and logopenic variant PPA (lvPPA).



    The clinical manifestations of primary progressive aphasia are characterized by isolated, progressive, and progressive decline in language function, most of which begin between the ages of 55 and 65, with a higher incidence in men than in women
    .


    4.



    The PPA typing and clinical diagnosis proposed by Gorno-Tempini et al.


    5.



    Before the classification diagnosis, the language function assessment can be performed, the main assessment content is as follows:


            


    VI.
    Treatment and prospect of primary progressive aphasia


    With the advent of a new generation of improved treatment options for diseases, widely accepted clinical standards, supplemented by biomarkers, will become critical
    in the coming years.

    In the future, it is hoped that it can be thoroughly treated
    through technologies such as gene regulation and monoclonal antibodies.


    Reference:Gorno-Tempini, M.
    L.
    , Hillis, A.
    E.
    , Weintraub, S.
    , Kertesz, A.
    , Mendez, M.
    , Cappa, S.
    F.
    , Ogar, J.
    M.
    , Rohrer, J.
    D.
    , Black, S.
    , Boeve, B.
    F.
    , Manes, F.
    , Dronkers, N.
    F.
    , Vandenberghe, R.
    , Rascovsky, K.
    , Patterson, K.
    , Miller, B.
    L.
    , Knopman, D.
    S.
    , Hodges, J.
    R.
    , Mesulam, M.
    M.
    , & Grossman, M.
    (2011).
    Classification of primary progressive aphasia and its variants.
    Neurology, 76(11), 1006–1014.
    https://doi.
    org/10.
    1212/WNL.
    0b013e31821103e6


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.